Grant Guidelines and Applications
Funded Investigator Ruslan Medzhitov is interviewed at the Scientific Advisory Workshop, 2018
The Scleroderma Research Foundation is continually looking for opportunities to increase understanding of scleroderma pathogenesis and to promote the design and development of innovative therapeutic approaches. We encourage applications from current scleroderma specialists as well as from those who have not previously worked on scleroderma.
Research grant applications for the following grants are considered:
SAB member Antony Rosen at the Scientific Advisory Workshop, 2018
The specific number of projects to be funded will depend on the merit and scope of the applications received and the availability of funds.
Funding support from the SRF may NOT be used for administrative overhead, indirect expenses, or other institutional charges. The sole exception to this prohibition is that the SRF will pay indirect costs of up to 7.5% of the direct project costs for multi-center (including more than 10 distinct clinical centers), longitudinal patient studies (with an agreement for at least 3 years of follow-up) that are intended to enroll more than 1,000 scleroderma patients.